Epidermal Growth Factor Receptor and Human Epidermal Growth Receptor 2 Expression in Parotid Mucoepidermoid Carcinoma: Possible Implications for Targeted Therapy

Oncology Reports - Greece
doi 10.3892/or.19.2.435
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Expression of Growth Factor Receptor Family Before and After Targeted Therapy in Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer Tissues

Korean Journal of Clinical Oncology
2015English

Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Breast Cancer

Expert Opinion on Biological Therapy
Drug DiscoveryClinical BiochemistryPharmacology
2013English

Baby Steps: Pregnancy Outcomes After Human Epidermal Growth Factor Receptor 2-Targeted Therapy

Cancer
Cancer ResearchOncology
2018English

The Epidermal Growth Factor Receptor Pathway: A Model for Targeted Therapy

Clinical Cancer Research
Cancer ResearchOncology
2006English

Epidermal Growth Factor Receptor in Human Glioma

Journal of Neurosurgery
SurgeryNeurology
1989English

Treatment of Pancreatic Cancer With Epidermal Growth Factor Receptor-Targeted Therapy

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

Anti-Epidermal Growth Factor Receptor Gene Therapy for Glioblastoma

PLoS ONE
Multidisciplinary
2016English

Targeting the Human Epidermal Growth Factor Receptor 2 in Esophageal Cancer

Cancer Control
MedicineOncologyHematology
2013English

Impact of Epidermal Growth Factor Receptor Gene Expression Level on Clinical Outcomes in Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma Patients Taking First-Line Epidermal Growth Factor Receptor–tyrosine Kinase Inhibitors

Tumor Biology
MedicineCancer Research
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy